These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 24308004

  • 1. Improved scFv anti-HIV-1 p17 binding affinity guided from the theoretical calculation of pairwise decomposition energies and computational alanine scanning.
    Tue-ngeun P, Kodchakorn K, Nimmanpipug P, Lawan N, Nangola S, Tayapiwatana C, Rahman NA, Zain SM, Lee VS.
    Biomed Res Int; 2013; 2013():713585. PubMed ID: 24308004
    [Abstract] [Full Text] [Related]

  • 2. Pairwise decomposition of residue interaction energies of single chain Fv with HIV-1 p17 epitope variants.
    Lee VS, Tue-ngeun P, Nangola S, Kitidee K, Jitonnom J, Nimmanpipug P, Jiranusornkul S, Tayapiwatana C.
    Mol Immunol; 2010 Feb; 47(5):982-90. PubMed ID: 20022377
    [Abstract] [Full Text] [Related]

  • 3. Baculovirus display of single chain antibody (scFv) using a novel signal peptide.
    Kitidee K, Nangola S, Gonzalez G, Boulanger P, Tayapiwatana C, Hong SS.
    BMC Biotechnol; 2010 Nov 19; 10():80. PubMed ID: 21092083
    [Abstract] [Full Text] [Related]

  • 4. Enhanced production of functional extracellular single chain variable fragment against HIV-1 matrix protein from Escherichia coli by sequential simplex optimization.
    Intachai K, Singboottra P, Leksawasdi N, Kasinrerk W, Tayapiwatana C, Butr-Indr B.
    Prep Biochem Biotechnol; 2015 Nov 19; 45(1):56-68. PubMed ID: 24884357
    [Abstract] [Full Text] [Related]

  • 5. Multiparameter optimization method and enhanced production of secreted recombinant single-chain variable fragment against the HIV-1 P17 protein from Escherichia coli by fed-batch fermentation.
    Paopang P, Kasinrerk W, Tayapiwatana C, Seesuriyachan P, Butr-Indr B.
    Prep Biochem Biotechnol; 2016 Nov 19; 46(3):305-12. PubMed ID: 25831436
    [Abstract] [Full Text] [Related]

  • 6. Three antigenic regions in p17 of human immunodeficiency virus type 1 (HIV-1) revealed by mouse monoclonal antibodies and human antibodies in HIV-1 carrier sera.
    Liu X, Ota A, Watanabe M, Ueda S, Saitoh A, Shinagawa H, Nakata A, Kurimura T, Wang X, Zhao Y.
    Microbiol Immunol; 1995 Nov 19; 39(10):775-85. PubMed ID: 8577268
    [Abstract] [Full Text] [Related]

  • 7. In silico analysis of the different variable domain oriented single-chain variable fragment antibody-antigen complexes.
    Koçer İ, Çelik E.
    J Biomol Struct Dyn; 2024 Jun 19; 42(9):4699-4709. PubMed ID: 37288797
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of HIV-1 replication in primary human T cells transduced with an intracellular anti-HIV-1 p17 antibody gene.
    Tewari D, Notkins AL, Zhou P.
    J Gene Med; 2003 Mar 19; 5(3):182-9. PubMed ID: 12666184
    [Abstract] [Full Text] [Related]

  • 9. Toward preserving the structure of the antigenic peptide p17-1 from the HIV-1 p17 protein in nanostructured films.
    Petri L, Ferreira M, Moraes ML.
    J Nanosci Nanotechnol; 2011 Aug 19; 11(8):6705-9. PubMed ID: 22103071
    [Abstract] [Full Text] [Related]

  • 10. Solution X-ray scattering reveals a novel structure of calmodulin complexed with a binding domain peptide from the HIV-1 matrix protein p17.
    Izumi Y, Watanabe H, Watanabe N, Aoyama A, Jinbo Y, Hayashi N.
    Biochemistry; 2008 Jul 08; 47(27):7158-66. PubMed ID: 18553937
    [Abstract] [Full Text] [Related]

  • 11. Effect of Glu12-His89 Interaction on Dynamic Structures in HIV-1 p17 Matrix Protein Elucidated by NMR.
    Konagaya Y, Miyakawa R, Sato M, Matsugami A, Watanabe S, Hayashi F, Kigawa T, Nishimura C.
    PLoS One; 2016 Jul 08; 11(12):e0167176. PubMed ID: 27907055
    [Abstract] [Full Text] [Related]

  • 12. Synthetic peptide AT20 coupled to KLH elicits antibodies against a conserved conformational epitope from a major functional area of the HIV-1 matrix protein p17.
    Fiorentini S, Marsico S, Becker PD, Iaria ML, Bruno R, Guzmán CA, Caruso A.
    Vaccine; 2008 Aug 26; 26(36):4758-65. PubMed ID: 18602957
    [Abstract] [Full Text] [Related]

  • 13. Cross-reactivity of anti-HIV-1-p17-derivative peptide (P30-52) antibody to Env V3 peptide.
    Ota A, Tanaka-Taya K, Ueda S.
    Hybridoma; 1999 Apr 26; 18(2):149-57. PubMed ID: 10380014
    [Abstract] [Full Text] [Related]

  • 14. Identification of amino acid residues critical for the B cell growth-promoting activity of HIV-1 matrix protein p17 variants.
    He W, Mazzuca P, Yuan W, Varney K, Bugatti A, Cagnotto A, Giagulli C, Rusnati M, Marsico S, Diomede L, Salmona M, Caruso A, Lu W, Caccuri F.
    Biochim Biophys Acta Gen Subj; 2019 Jan 26; 1863(1):13-24. PubMed ID: 30248376
    [Abstract] [Full Text] [Related]

  • 15. HIV-1 matrix protein p17 misfolding forms toxic amyloidogenic assemblies that induce neurocognitive disorders.
    Zeinolabediny Y, Caccuri F, Colombo L, Morelli F, Romeo M, Rossi A, Schiarea S, Ciaramelli C, Airoldi C, Weston R, Donghui L, Krupinski J, Corpas R, García-Lara E, Sarroca S, Sanfeliu C, Slevin M, Caruso A, Salmona M, Diomede L.
    Sci Rep; 2017 Sep 04; 7(1):10313. PubMed ID: 28871125
    [Abstract] [Full Text] [Related]

  • 16. Molecular interaction studies of HIV-1 matrix protein p17 and heparin: identification of the heparin-binding motif of p17 as a target for the development of multitarget antagonists.
    Bugatti A, Giagulli C, Urbinati C, Caccuri F, Chiodelli P, Oreste P, Fiorentini S, Orro A, Milanesi L, D'Ursi P, Caruso A, Rusnati M.
    J Biol Chem; 2013 Jan 11; 288(2):1150-61. PubMed ID: 23166320
    [Abstract] [Full Text] [Related]

  • 17. Preclinical studies on immunogenicity of the HIV-1 p17-based synthetic peptide AT20-KLH.
    Fiorentini S, Marini E, Bozzo L, Trainini L, Saadoune L, Avolio M, Pontillo A, Bonfanti C, Sarmientos P, Caruso A.
    Biopolymers; 2004 Jan 11; 76(4):334-43. PubMed ID: 15386266
    [Abstract] [Full Text] [Related]

  • 18. Neutralization of human immunodeficiency virus type 1 (HIV-1) with antibody from carriers' plasma against HIV-1 protein p17.
    Kageyama S, Katsumoto T, Taniguchi K, Ismail SI, Shimmen T, Sasao F, Gao M, Owatari S, Wakamiya N, Tsuchie H, Ueda S, Shiraki K, Kurimura T.
    Acta Virol; 1996 Sep 11; 40(4):195-200. PubMed ID: 9014009
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of the affinity measurement of anti-HIV-1 p17 monoclonal antibody by BIAcore.
    Ota A, Ueda S.
    Hybridoma; 1998 Oct 11; 17(5):471-7. PubMed ID: 9873993
    [Abstract] [Full Text] [Related]

  • 20. HIV-1 matrix protein p17: a candidate antigen for therapeutic vaccines against AIDS.
    Fiorentini S, Giagulli C, Caccuri F, Magiera AK, Caruso A.
    Pharmacol Ther; 2010 Dec 11; 128(3):433-44. PubMed ID: 20816696
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.